Literature DB >> 23643680

Parathyroid hormone reverses radiation induced hypovascularity in a murine model of distraction osteogenesis.

Stephen Y Kang1, Sagar S Deshpande, Alexis Donneys, Jose J Rodriguez, Noah S Nelson, Peter A Felice, Douglas B Chepeha, Steven R Buchman.   

Abstract

BACKGROUND: Radiation treatment results in a severe diminution of osseous vascularity. Intermittent parathyroid hormone (PTH) has been shown to have an anabolic effect on osteogenesis, though its impact on angiogenesis remains unknown. In this murine model of distraction osteogenesis, we hypothesize that radiation treatment will result in a diminution of vascularity in the distracted regenerate and that delivery of intermittent systemic PTH will promote angiogenesis and reverse radiation induced hypovascularity.
MATERIALS AND METHODS: Nineteen Lewis rats were divided into three groups. All groups underwent distraction of the left mandible. Two groups received radiation treatment to the left mandible prior to distraction, and one of these groups was treated with intermittent subcutaneous PTH (60 μg/kg, once daily) beginning on the first day of distraction for a total duration of 21 days. One group underwent mandibular distraction alone, without radiation. After consolidation, the rats were perfused and imaged with micro-CT angiography and quantitative vascular analysis was performed.
RESULTS: Radiation treatment resulted in a severe diminution of osseous vascularity in the distracted regenerate. In irradiated mandibles undergoing distraction osteogenesis, treatment with intermittent PTH resulted in significant increases in vessel volume fraction, vessel thickness, vessel number, degree of anisotropy, and a significant decrease in vessel separation (p < 0.05). No significant difference in quantitative vascularity existed between the group that was irradiated, distracted and treated with PTH and the group that underwent distraction osteogenesis without radiation treatment.
CONCLUSIONS: We quantitatively demonstrate that radiation treatment results in a significant depletion of osseous vascularity, and that intermittent administration of PTH reverses radiation induced hypovascularity in the murine mandible undergoing distraction osteogenesis. While the precise mechanism of PTH-induced angiogenesis remains to be elucidated, this report adds a key component to the pleotropic effect of intermittent PTH on bone formation and further supports the potential use of PTH to enhance osseous regeneration in the irradiated mandible.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; CT; DA; DO; Distraction osteogenesis; Gy; HIFα; Mandible; POD; PTH; Parathyroid hormone; ROI; Radiation; VEGF; VN; VS; VT; VVF; XRT; computed tomography; degree of anisotropy; distraction osteogenesis; gray; hypoxia-inducible factor-1 alpha; parathyroid hormone; postoperative day; radiation treatment; region of interest; vascular endothelial growth factor; vessel number; vessel separation; vessel thickness; vessel volume fraction

Mesh:

Substances:

Year:  2013        PMID: 23643680      PMCID: PMC3758112          DOI: 10.1016/j.bone.2013.04.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  54 in total

Review 1.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

2.  Osteosarcoma and teriparatide?

Authors:  Kristine D Harper; John H Krege; Robert Marcus; Bruce H Mitlak
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

3.  Dose-response effect of human equivalent radiation in the murine mandible: part I. A histomorphometric assessment.

Authors:  Catherine N Tchanque-Fossuo; Laura A Monson; Aaron S Farberg; Alexis Donneys; Aria J Zehtabzadeh; Elizabeth R Razdolsky; Steven R Buchman
Journal:  Plast Reconstr Surg       Date:  2011-07       Impact factor: 4.730

Review 4.  Management of osteoradionecrosis of the mandible.

Authors:  J R Sanger; H S Matloub; N J Yousif; D L Larson
Journal:  Clin Plast Surg       Date:  1993-07       Impact factor: 2.017

5.  Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women.

Authors:  Peter Peichl; Lukas A Holzer; Richard Maier; Gerold Holzer
Journal:  J Bone Joint Surg Am       Date:  2011-09-07       Impact factor: 5.284

6.  Teriparatide improves early callus formation in distal radial fractures.

Authors:  Per Aspenberg; Torsten Johansson
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

Review 7.  Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.

Authors:  Armen H Tashjian; Bruce A Chabner
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

8.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

9.  Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor.

Authors:  G Rashid; J Bernheim; J Green; S Benchetrit
Journal:  Eur J Clin Invest       Date:  2008-11       Impact factor: 4.686

10.  Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.

Authors:  Teresita Bellido; A Afshan Ali; Lilian I Plotkin; Qiang Fu; Igor Gubrij; Paula K Roberson; Robert S Weinstein; Charles A O'Brien; Stavros C Manolagas; Robert L Jilka
Journal:  J Biol Chem       Date:  2003-10-01       Impact factor: 5.157

View more
  9 in total

1.  Engraftment and bone mass are enhanced by PTHrP 1-34 in ectopically transplanted vertebrae (vossicle model) and can be non-invasively monitored with bioluminescence and fluorescence imaging.

Authors:  Blake Eason Hildreth; Michelle M Williams; Katarzyna A Dembek; Krista M Hernon; Thomas J Rosol; Ramiro E Toribio
Journal:  Transgenic Res       Date:  2015-08-14       Impact factor: 2.788

2.  Bone Regeneration Is Promoted by Orally Administered Bovine Lactoferrin in a Rabbit Tibial Distraction Osteogenesis Model.

Authors:  Wenyang Li; Songsong Zhu; Jing Hu
Journal:  Clin Orthop Relat Res       Date:  2015-03-31       Impact factor: 4.176

Review 3.  Current concepts of bone tissue engineering for craniofacial bone defect repair.

Authors:  Brian Alan Fishero; Nikita Kohli; Anusuya Das; John Jared Christophel; Quanjun Cui
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-18

4.  Vascular analysis as a proxy for mechanostransduction response in an isogenic, irradiated murine model of mandibular distraction osteogenesis.

Authors:  Sagar S Deshpande; Alexis Donneys; Stephen Y Kang; Erin E Page; Peter A Felice; Lauren Kiryakoza; Noah S Nelson; Jose Rodriguez; Samir S Deshpande; Steven R Buchman
Journal:  Microvasc Res       Date:  2014-08-27       Impact factor: 3.514

5.  Influence of low-level laser therapy on inflammation, collagen fiber maturation, and tertiary dentin deposition in the pulp of bleached teeth.

Authors:  Amanda Miyuki Terayama; Francine Benetti; Juliana Maria de Araújo Lopes; Jéssica Galbiati Barbosa; Isabela Joane Prado Silva; Gustavo Sivieri-Araújo; André Luiz Fraga Briso; Luciano Tavares Angelo Cintra
Journal:  Clin Oral Investig       Date:  2020-03-20       Impact factor: 3.573

6.  A Histomorphometric Analysis of Radiation Damage in an Isogenic Murine Model of Distraction Osteogenesis.

Authors:  Alexander R Zheutlin; Sagar S Deshpande; Noah S Nelson; Yekaterina Polyatskaya; Jose J Rodriguez; Alexis Donneys; Steven R Buchman
Journal:  J Oral Maxillofac Surg       Date:  2015-08-07       Impact factor: 1.895

7.  Effects of combined menaquinone-4 and PTH1-34 treatment on osetogenesis and angiogenesis in calvarial defect in osteopenic rats.

Authors:  She-Ji Weng; Zhong-Jie Xie; Zong-Yi Wu; De-Yi Yan; Jia-Hao Tang; Zi-Jian Shen; Hang Li; Bing-Li Bai; Viraj Boodhun; Xiang Da Eric Dong; Lei Yang
Journal:  Endocrine       Date:  2018-09-22       Impact factor: 3.633

8.  Intermittent Parathyroid Hormone Injection Can Decrease Femoral Head Collapse in the Vascular Deprivation of Rat Femoral Head Model.

Authors:  Chih-Wei Chiang; Wei-Chuan Chen; Chian-Her Lee; Chih-Hwa Chen
Journal:  Indian J Orthop       Date:  2019 Mar-Apr       Impact factor: 1.251

9.  Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts.

Authors:  Ben Antebi; Longze Zhang; Dmitriy Sheyn; Gadi Pelled; Xinping Zhang; Zulma Gazit; Edward M Schwarz; Dan Gazit
Journal:  Bioengineering (Basel)       Date:  2016-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.